3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Melanoma
2
Endometrial Neoplasms
2
Solid Tumors
1
Sarcoma
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharangeal Cancer
1
Lymphoma, T-Cell, Peripheral
1
Lung Neoplasms
1
Kidney Neoplasms
1
Kidney Diseases
1
Hemangiosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Diffuse Intrinsic Pontine Glioma
1
CRC
1
Interventions
Nivolumab
5
Cyclophosphamide
5
pembrolizumab
4
Ipilimumab
4
fludarabine phosphate
3
fludarabine
3
Specimen Handling
3
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
Blood Specimen Collection
2
trametinib
1
tebentafusp
1
ruxolitinib
1
omipalisib
1
olaparib
1
lifileucel
1
binimetinib
1
belinostat
1
avelumab
1
Vorinostat
1
Valproic Acid
1
Tape Recording
1
Sunitinib
1
Spinal Puncture
1
Practice Guidelines as Topic
1
Pemetrexed
1
Methods
1
LY2940680
1
Iodized Oil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
spartalizumab
×
90 days
×
Clear all
No trials found.